Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

VOR holding history

Vor Biopharma Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VOR overviewAll 13F holders of VORFull Q2 2026 holdings

Shares (Q2 2026)
493,278
Value
$9.08M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of VOR by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026493,278$9.08M<0.1%+4,910+1.0%AddedHolders
Q1 2026488,368$8.71M<0.1%+196,250+67.2%AddedHolders
Q4 2025292,118$3.82M<0.1%+216,209+284.8%AddedHolders
Q3 202575,909$3.70M<0.1%−673−0.9%ReducedConverted for a 1-for-20 splitHolders
Q2 20251,531,636$2.48M<0.1%+1,523,181+18,015.2%AddedHolders
Q1 20258,455$6.07K<0.1%+8,455NewHolders
Q3 20240$00.0%−11,201−100.0%Sold outHolders
Q2 202411,201$11.2K<0.1%−27,182−70.8%ReducedHolders
Q1 202438,383$91.0K<0.1%+450+1.2%AddedHolders
Q4 202337,933$85.3K<0.1%+21,573+131.9%AddedHolders
Q3 202316,360$34.7K<0.1%+6,142+60.1%AddedHolders
Q2 202310,218$31.6K<0.1%+10,218NewHolders
Q1 20230$00.0%−4,087−100.0%Sold outHolders
Q4 20224,087$27.2K<0.1%+4,087NewHolders
Q3 20220$00.0%−865−100.0%Sold outHolders
Q2 2022865$4.00K<0.1%+865NewHolders
Q1 20220$00.0%−7,167−100.0%Sold outHolders
Q4 20217,167$83.0K<0.1%+7,130+19,270.3%AddedHolders
Q3 202137$1.00K<0.1%−5,081−99.3%ReducedHolders
Q2 20215,118$95.0K<0.1%−1,975−27.8%ReducedHolders
Q1 20217,093$306.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.